Showing 8 of 8 recruiting trials for “best-vitelliform-macular-dystrophy”
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
RecruitingNCT06805474 ↗
A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
Vasodilator and Exercise Study for DMD (VASO-REx)
👨⚕️ Tanja Taivassalo, Ph.D., University of Florida, College of Medicine, Department of Physiology and Aging📍 1 site📅 Started Jun 2024View details ↗
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
👨⚕️ Joanne M. Donovan, MD, PhD, Edgewise Therapeutics, Inc.📍 46 sites📅 Started Nov 2023View details ↗
RecruitingNCT05809635 ↗
Study of BEST1 Vitelliform Macular Dystrophy
RecruitingNCT05019625 ↗
Biomarker Development for Muscular Dystrophies
👨⚕️ Thurman M. Wheeler, MD, Massachusetts General Hospital📍 5 sites📅 Started Feb 2015View details ↗
RecruitingNCT02069756 ↗
The Duchenne Registry
RecruitingNCT00390104 ↗
Molecular Analysis of Patients With Neuromuscular Disease
👨⚕️ Louis M Kunkel, PhD, Boston Children's Hospital/Harvard Medical School📍 1 site📅 Started Jan 2002View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →